MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2021

    Effect of Venglustat by GBA Mutation Severity in Patients With Parkinson’s Disease

    J. Peterschmitt, N. Giladi, R. Alcalay, G. Cutter, G. Höglinger, A. Schapira, C. Scherzer, T. Simuni, T. Gurevich, T. Gasser, C. Pacchetti, K. Marek, P. Minini, S. Sardi (Cambridge, USA)

    Objective: Report outcomes from Part 2 of the phase 2 MOVES-PD trial (NCT02906020) in patients with PD stratified by glucocerebrosidase (GBA) gene mutation severity. Background:…
  • MDS Virtual Congress 2021

    Causes of deaths in patients with Parkinson’s disease in the era before the use of modern drug therapy and at the present time

    S. Shtaimets (Omsk, Russian Federation)

    Objective: to study the impact of modern pharmacotherapy of Parkinson's disease (PD) on the main causes of death. Background: the modern era of the use…
  • MDS Virtual Congress 2021

    Hemiparkinsonism Due to Diencephalic Lesion with 24 Years of Levodopa Response and Only Mild Dyskinesia

    S. Filipović (Beograd, Serbia)

    Objective: To present a case of a long-standing hemiparkinsonism due to cerebral lesion with a continuous response to a stable dose of levodopa with only…
  • MDS Virtual Congress 2021

    A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson’s disease

    C. Fevga, Y. Park, E. Lohmann, A J. Kievit, G J. Breedveld, F. Ferraro, L. de Boer, R. van Minkelen, H. Hanagasi, A. Boon, W. Wang, G A. Petsko, Q Q. Hoang, M. Emre, V. Bonifati (Rotterdam, Netherlands)

    Objective: To report the identification of a novel variant in the gene encoding alpha-synuclein (SNCA), segregating with Parkinson’s Disease (PD) in two families of Turkish…
  • MDS Virtual Congress 2021

    Neurofilament light is related to fractional anisotropy in early Parkinson’s diesease

    T. Welton, Y. Tan, S. Saffari, N. Chia, S. Ng, Z. Lu, A. Yong, X. Choi, D. Heng, YC. Shih, S. Hartono, W. Lee, Z. Xu, K. Tay, WL. Au, EK. Tan, LL. Chan, A. Ng, L. Tan (Singapore, Singapore)

    Objective: We aimed to determine whether plasma NfL reflects changes in brain white matter integrity as measured using fractional anisotropy (FA) in patients with early…
  • MDS Virtual Congress 2021

    Apathy: an underestimated feature in premotor period of GBA and LRRK2 non-manifesting mutation carriers.

    I. Pachi, C. Koros, A. Simitsi, D. Papadimitriou, A. Bougea, A. Prentakis, N. Papagiannakis, M. Bozi, R. Antonelou, E. Angelopoulou, I. Beratis, M. Stamelou, X. Trapali, S. Papageorgiou, L. Stefanis (Athens, Greece)

    Objective: The aim was to detect the differences between GBA and LRRK2 mutation carriers without Parkinson’s disease and healthy controls (HC) on neuropsychiatric symptoms. Background:…
  • MDS Virtual Congress 2021

    Parkinson’s Disease Functional Impacts Digital Instrument (PD-FIDI): Studies Preceding Clinical Validation

    A. Pearlmutter, N. Wong, M. Levin, R. Zheng, R. Ellis, P. Kelly, M. Peterschmitt (Cambridge, USA)

    Objective: Summarize the findings from 3 developmental studies of the Parkinson’s Disease Functional Impacts Digital Instrument (PD-FIDI) – a novel endpoint for assessing PD symptoms.…
  • MDS Virtual Congress 2021

    Determining the content of a clinician-rated tool for freezing of gait severity

    A. Scully, B. de Oliveira, K. Hill, D. Tan, YH. Pua, R. Clark, E. Burton (Bentley, Australia)

    Objective: This study aimed to determine clinician’s ratings of the most important triggering circumstances to be examined and aspects of freezing of gait (FOG) to…
  • MDS Virtual Congress 2021

    An International Pre-Implementation Survey To Assess The Acceptability Of Telemedicine As An Alternative To In-Person Clinic Consultations For PD

    O. Ojo, JH. Ahn, Z. Aldaajani, J. Bajwa, A. Bustillo, A. Cardozo, M. Dekker, E. Eldayem, Z. Mari, A. Shalash, M. Shackleford, M. Spindler, J. Youn, E. Cubo, N. Okubadejo (Idi-Araba, Nigeria)

    Objective: To assess the acceptability of virtual consultations as an option for out-patient clinic consultations for PD Background: The practice of telemedicine increased dramatically on…
  • MDS Virtual Congress 2021

    Single-Trajectory Multiple-Target Deep Brain Stimulation to treat Mobility and Cognition in Parkinson’s Disease: a Double-Blind, Randomized, Cross-Over Pilot Study

    S. Sasikumar, M. Cohn, I. Harmsen, A. Loh, S. Kalia, A. Lozano, A. Fasano (Toronto, Canada)

    Objective: To assess the benefit of deep brain stimulation (DBS) to improve cognition in Parkinson’s Disease (PD). Background: Patients with advanced PD suffer from both…
  • « Previous Page
  • 1
  • …
  • 68
  • 69
  • 70
  • 71
  • 72
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley